Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

ADHD 환자에 대한 OROS-Methylphenidate 약물치료의 부작용과 관련요인들에 대한 연구The Side Effects and Correlates of OROS-Methylphenidate in the Treatment of Children and Adolescents with ADHD

Other Titles
The Side Effects and Correlates of OROS-Methylphenidate in the Treatment of Children and Adolescents with ADHD
Issue Date
대한소아청소년 정신의학회
ADHD·OROS-MPH·부작용·약물반응.; ADHD·OROS-MPH·Side Effects·Drug Response.
소아 청소년 정신의학, v.21, no.2, pp.63 - 71
Journal Title
소아 청소년 정신의학
Start Page
End Page
Objectives:The aim of this study was to investigate the effect of the clinical and demographic variables such as body weight, dosage, family history of attention-deficit hyperactivity disorder (ADHD), and psychiatric co-morbidity on the side-effects of OROS-Methylphenidate (OROS-MPH), and to evaluate the relationship between drug response and side effect severity. Methods:A total of 144 children (ages 6-18) with diagnosed ADHD were treated with OROS-MPH. Children were examined at baseline and after 1, 3, 6, 9, and 12 weeks of each treatment condition. The stimulant drug side effect rating scale (SERS), pulse rate, systolic blood pressure, diastolic blood pressure, and electrocardiogram (ECG) were evaluated to assess side effect profiles. Changes in these parameters from baseline were examined and analyzed. Results:Anorexia (30.95%) and insomnia (13.10%) were the most commonly reported side effects during this study. Insomnia and loss of appetite score increased at one week follow-up, but was sustained or decreased as treatment progressed. Small but significant increases in pulse rate and diastolic blood pressure were observed during treatment;however, no clinically meaningful changes in ECG parameters were noted during the study. Low body weight, high dosage of OROS-MPH, and family history of ADHD were associated with cardiovascular side effect. In contrast, there was no significant relationship between OROS-MPH treatment response and the severity of side effect and no difference resulted between the responder and non-responder groups with respect to OROS-MPH dosage in the 12 weeks of follow-up. Conclusion:To the best of our knowledge, this study is the first Korean study to investigate comprehensive side effect profiles and their correlates in OROS-MPH treatment for ADHD children. OROS-MPH was well tolerated with no clinically significant side effects during the treatment period. In conclusion, low body weight, high dosage of OROSMPH, and family history of ADHD could be used as predictive factors in increasing pulse rate and blood pressure.
Files in This Item
Go to Link
Appears in
생활과학대학 > 아동복지학부 > 1. Journal Articles


Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ha, Eun Hye photo

Ha, Eun Hye
생활과학대학 (아동복지학부)
Read more


Total Views & Downloads